Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Unknown 2Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Renal Insufficiency 1Pancreatic Neoplasms 1Neoplasms, Adipose Tissue 1Myelodysplastic Syndromes 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, Follicular 1Kidney Failure, Chronic 1Diabetes Mellitus, Type 2 1Body Weight 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Metformin 91Clomiphene 31Letrozole 23Inositol 19Folic Acid 11Chorionic Gonadotropin 11Exercise 10High-Intensity Interval Training 9drospirenone and ethinyl estradiol combination 8Ethinyl Estradiol 8Contraceptives, Oral 8Cholecalciferol 8cetrorelix 7Tablets 7Progesterone 7Menotropins 6follitropin alfa 5Pioglitazone 5Liraglutide 5Exenatide 5Cyproterone Acetate 5Caloric Restriction 5Vitamin D 4Triptorelin Pamoate 4Surveys and Questionnaires 4Sugars 4Spironolactone 4Glycoprotein Hormones, alpha Subunit 4Fish Oils 4Estradiol 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Polycystic Ovary Syndrome × Sitagliptin Phosphate × Clear all
NCT02122380 2020-05-08

The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome

Vanderbilt University Medical Center

Phase 4 Completed
23 enrolled 12 charts

Polycystic Ovary Syndrome

NCT02941445 2016-10-21

Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

University Medical Centre Ljubljana

Phase 4 Completed
24 enrolled

Body Weight, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡